MediChip®, a novel 3D printed biodegradable mesh that delivers drugs in a localized sustained manner for cancer indications with reduced systemic side effects. MediChip’s flexible nature targets mostly the tumor cells and the hard-to-reach tumor sites by delivering the cancer drugs (FDA approved APIs; gemcitabine and 5-FU[FOLFIRI]) directly to the site of the tumor.